These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 29446989)

  • 1. Comparison of the efficacy of two human fibrinogen concentrates to treat dilutional coagulopathy in vitro.
    Haas T; Cushing MM; Asmis LM
    Scand J Clin Lab Invest; 2018 May; 78(3):230-235. PubMed ID: 29446989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of fibrinogen concentrate and factor XIII on thromboelastometry in 33% diluted blood with albumin, gelatine, hydroxyethyl starch or saline in vitro.
    Schlimp CJ; Cadamuro J; Solomon C; Redl H; Schöchl H
    Blood Transfus; 2013 Oct; 11(4):510-7. PubMed ID: 23245725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrinogen and FXIII dose response effects on albumin-induced coagulopathy.
    Hanna J; Winstedt D; Schött U
    Scand J Clin Lab Invest; 2013 Oct; 73(7):553-62. PubMed ID: 24004348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correction of hypothermic and dilutional coagulopathy with concentrates of fibrinogen and factor XIII: an in vitro study with ROTEM.
    Winstedt D; Thomas OD; Nilsson F; Olanders K; Schött U
    Scand J Trauma Resusc Emerg Med; 2014 Dec; 22():73. PubMed ID: 25510409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The in vitro effects of fibrinogen concentrate, factor XIII and fresh frozen plasma on impaired clot formation after 60% dilution.
    Haas T; Fries D; Velik-Salchner C; Reif C; Klingler A; Innerhofer P
    Anesth Analg; 2008 May; 106(5):1360-5, table of contents. PubMed ID: 18420845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro factor XIII supplementation increases clot firmness in Rotation Thromboelastometry (ROTEM).
    Theusinger OM; Baulig W; Asmis LM; Seifert B; Spahn DR
    Thromb Haemost; 2010 Aug; 104(2):385-91. PubMed ID: 20431856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Two Different Fibrinogen Concentrates in an in vitro Model of Dilutional Coagulopathy.
    Groene P; Wiederkehr T; Kammerer T; Möhnle P; Maerte M; Bayer A; Görlinger K; Rehm M; Schäfer ST
    Transfus Med Hemother; 2020 Apr; 47(2):167-174. PubMed ID: 32355477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of the in vitro effects of three fibrinogen concentrates on clot strength in blood samples from cardiac surgery patients.
    Stolt H; Shams Hakimi C; Singh S; Jeppsson A; Karlsson M
    Acta Anaesthesiol Scand; 2021 Nov; 65(10):1439-1446. PubMed ID: 34368944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics, clot strength and safety of a new fibrinogen concentrate: randomized comparison with active control in congenital fibrinogen deficiency.
    Ross C; Rangarajan S; Karimi M; Toogeh G; Apte S; Lissitchkov T; Acharya S; Manco-Johnson MJ; Srivastava A; Brand B; Schwartz BA; Knaub S; Peyvandi F
    J Thromb Haemost; 2018 Feb; 16(2):253-261. PubMed ID: 29220876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Albumin-induced coagulopathy is less severe and more effectively reversed with fibrinogen concentrate than is synthetic colloid-induced coagulopathy.
    Winstedt D; Hanna J; Schött U
    Scand J Clin Lab Invest; 2013 Mar; 73(2):161-9. PubMed ID: 23368782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The in-vitro effect of fibrinogen, factor XIII and thrombin-activatable fibrinolysis inhibitor on clot formation and susceptibility to tissue plasminogen activator-induced fibrinolysis in hemodilution model.
    Shenkman B; Livnat T; Lubetsky A; Tamarin I; Budnik I; Einav Y; Martinowitz U
    Blood Coagul Fibrinolysis; 2012 Jul; 23(5):370-8. PubMed ID: 22498982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is dilutional coagulopathy induced by different colloids reversible by replacement of fibrinogen and factor XIII concentrates?
    Kind SL; Spahn-Nett GH; Emmert MY; Eismon J; Seifert B; Spahn DR; Theusinger OM
    Anesth Analg; 2013 Nov; 117(5):1063-71. PubMed ID: 24029856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of a new pathogen-reduced cryoprecipitate stored 5 days after thawing to correct dilutional coagulopathy in vitro.
    Cushing MM; Asmis LM; Harris RM; DeSimone RA; Hill S; Ivascu N; Haas T
    Transfusion; 2019 May; 59(5):1818-1826. PubMed ID: 30719724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of laboratory coagulation tests and clotting factor levels on Rotation Thromboelastometry (ROTEM(R)) during major surgery with hemorrhage.
    Theusinger OM; Schröder CM; Eismon J; Emmert MY; Seifert B; Spahn DR; Baulig W
    Anesth Analg; 2013 Aug; 117(2):314-21. PubMed ID: 23780419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of in vitro hemodilution and fibrinogen concentrate substitution on thromboelastometry analysis in patients qualified for liver transplantation - preliminary results.
    Nicińska B; Pluta J; Kosieradzki M; Lągiewska B; Wasiak D; Lazowski T; Chmura A; Trzebicki J
    Transplant Proc; 2014 Oct; 46(8):2758-61. PubMed ID: 25380911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro effects of different sources of fibrinogen supplementation on clot initiation and stability in a model of dilutional coagulopathy.
    Schäfer N; Driessen A; Bauerfeind U; Fröhlich M; Ofir J; Stürmer EK; Maegele M
    Transfus Med; 2016 Oct; 26(5):373-380. PubMed ID: 27506588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factor XIII levels, clot strength, and impact of fibrinogen concentrate in infants undergoing cardiopulmonary bypass: a mechanistic sub-study of the FIBCON trial.
    Siemens K; Hunt BJ; Parmar K; Taylor D; Salih C; Tibby SM
    Br J Anaesth; 2023 Feb; 130(2):175-182. PubMed ID: 36371257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High haematocrit in cyanotic congenital heart disease affects how fibrinogen activity is determined by rotational thromboelastometry.
    Westbury SK; Lee K; Reilly-Stitt C; Tulloh R; Mumford AD
    Thromb Res; 2013 Aug; 132(2):e145-51. PubMed ID: 23906940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between standard laboratory and functional tests of coagulation in dilutional coagulopathy: an in vitro study.
    Krzych LJ; Czempik PF
    J Physiol Pharmacol; 2017 Aug; 68(4):637-645. PubMed ID: 29151081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of haemodilution with succinylated gelatin solution on coagulation in vitro as assessed by thromboelastometry and impedance (multiple electrode) aggregometry.
    Kam P; Varanasi S; Yang KX
    Anaesth Intensive Care; 2018 May; 46(3):272-277. PubMed ID: 29716485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.